Ondine Biomedical Inc. (OBI.L)
GBp 8.13
(4.84%)
GBp 8.13
(4.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Million | 638 Thousand | 2.56 Million | 1.79 Million | 464 Thousand | 373 Thousand |
| Cost of Revenue | 500 Thousand | 351 Thousand | 1.31 Million | 1.14 Million | 328 Thousand | 485 Thousand |
| Gross Profit | 703 Thousand | 287 Thousand | 1.25 Million | 649 Thousand | 136 Thousand | -112 Thousand |
| Operating Expenses | 15.5 Million | 19.05 Million | 18.77 Million | 16.52 Million | 14.16 Million | 16.42 Million |
| Selling, General and Administrative Expenses | 9.79 Million | 12.31 Million | 13.33 Million | 12.03 Million | 9.55 Million | 11.43 Million |
| Research and Development Expenses | 5.14 Million | 6.28 Million | 4.98 Million | 3.3 Million | 3.42 Million | 4.09 Million |
| Other Expenses | 570 Thousand | 460 Thousand | 458 Thousand | 1.17 Million | 1.18 Million | -30 Thousand |
| Cost and Expenses | 16 Million | 19.4 Million | 20.08 Million | 17.66 Million | 14.49 Million | 16.9 Million |
| Operating Income | -14.8 Million | -18.76 Million | -17.52 Million | -15.87 Million | -14.02 Million | -16.53 Million |
| Interest Expense | 38 Thousand | 30 Thousand | 1.19 Million | 491 Thousand | 179 Thousand | 127 Thousand |
| Income Tax Expense | - | 1.41 Million | 32.73 Million | 710 Thousand | 174 Thousand | 124 Thousand |
| Earnings before Tax | -14.41 Million | -19.37 Million | -50.08 Million | -16.2 Million | -13.99 Million | -16.65 Million |
| Net Income | -14.41 Million | -20.78 Million | -82.81 Million | -16.91 Million | -14.16 Million | -16.65 Million |
| Earnings Per Share Basic | -0.07 | -0.11 | -1.04 | -0.09 | -0.07 | -0.09 |
| Earnings Per Share Diluted | -0.07 | -0.11 | -1.04 | -0.09 | -0.07 | -0.09 |
| Weighted Average Shares Outstanding | 197.11 Million | 194.58 Million | 79.63 Million | 194.58 Million | 194.58 Million | 194.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 197.11 Million | 194.58 Million | 79.63 Million | 194.58 Million | 194.58 Million | 194.58 Million |
| Gross Margin | 0.58 | 0.45 | 0.49 | 0.36 | 0.29 | -0.30 |
| EBIT Margin | -11.74 | -27.33 | -6.56 | -7.97 | -27.14 | -41.85 |
| Profit Margin | -11.98 | -32.58 | -32.24 | -9.45 | -30.53 | -44.65 |
| EBITDA | -14.12 Million | -18.84 Million | -16.84 Million | -14.56 Million | -12.59 Million | -15.61 Million |
| Earnings Before Tax Margin | -12.31 | -29.41 | -6.82 | -8.86 | -30.23 | -44.32 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 499.9 Thousand | 1.2 Million | 457.62 Thousand | 257.5 Thousand | 638 Thousand | 240.47 Thousand |
| Cost of Revenue | 350.34 Thousand | 500 Thousand | 353.7 Thousand | 283.38 Thousand | 351 Thousand | 300.59 Thousand |
| Gross Profit | 149.56 Thousand | 703 Thousand | 103.92 Thousand | -25.87 Thousand | 287 Thousand | -60.12 Thousand |
| Operating Expenses | 4.7 Million | 15.5 Million | 4.1 Million | 4.8 Million | 19.05 Million | 7.41 Million |
| Selling, General and Administrative Expenses | 2.78 Million | - | 2.35 Million | 3.49 Million | - | 4.23 Million |
| Research and Development Expenses | 1.92 Million | - | 1.74 Million | 1.31 Million | - | 2.32 Million |
| Other Expenses | -1.92 Million | -7000.00 | - | - | 460 Thousand | -850.62 Thousand |
| Cost and Expenses | 5.05 Million | 16 Million | 4.45 Million | 5.08 Million | 19.4 Million | 7.71 Million |
| Operating Income | -4.55 Million | -14.8 Million | -4 Million | -4.83 Million | -18.76 Million | -7.47 Million |
| Interest Expense | 12.8 Thousand | 38 Thousand | 10.62 Thousand | 12.03 Thousand | 30 Thousand | 13.43 Thousand |
| Income Tax Expense | - | 94 Thousand | 2.00 | 4.00 | 1.41 Million | -3.00 |
| Earnings before Tax | -4.51 Million | -14.41 Million | -3.84 Million | -4.75 Million | -19.37 Million | -6.9 Million |
| Net Income | -4.51 Million | -14.41 Million | -3.84 Million | -4.75 Million | -20.78 Million | -6.9 Million |
| Earnings Per Share Basic | -0.02 | - | -0.02 | -0.02 | - | -0.04 |
| Earnings Per Share Diluted | -0.02 | - | -0.02 | -0.02 | - | -0.04 |
| Weighted Average Shares Outstanding | 241.46 Million | 197.11 Million | 200.09 Million | 194.71 Million | 194.58 Million | 194.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 241.46 Million | 197.11 Million | 200.09 Million | 194.71 Million | 194.58 Million | 194.59 Million |
| Gross Margin | 0.30 | 0.58 | 0.23 | -0.10 | 0.45 | -0.25 |
| EBIT Margin | -9.01 | - | -8.38 | -18.05 | - | -30.41 |
| Profit Margin | -9.04 | -11.98 | -8.40 | -18.46 | -32.58 | -28.73 |
| EBITDA | -4.5 Million | - | -3.83 Million | -4.64 Million | - | -7.31 Million |
| Earnings Before Tax Margin | -9.12 | -12.31 | -8.74 | -18.76 | -29.41 | -31.08 |
TLS
8706
7367
RFSL
6830
1094